Latest News
-
Intraday Trade Call: Day Trading Stock Picks By Chandan Taparia Of Motilal Oswal On Thurday, 25 April -
Trade Setup: Nifty Continues Winning Streak Ahead of April F&O Expiry, Q4 Earnings In Focus -
Rs 10/Share Dividend: Record Date In Due Course; Buy The Banking Stock To Be Eligible? -
Stock Market Live Updates: Market Likely To Open With Minor Cuts; Nifty To Slide Below 22,400 -
Tech Mahindra Q4 Results Preview: Revenue May Fall, But Margins Seen To Expand; To Announce Dividend -
Rs. 7.75/Share Dividend: Record Date In Due Course; Buy The TATA Group Stock? -
Trade Call: Day Trading Stock Picks By Sumeet Bagadia of Choice Broking On Thursday, 25th April -
Swing Trading Guide: 3 Stock Picks By VLA Ambala On Thursday, 25th April -
HCL Tech Q4 Results, Dividend: EBIT Margins May Drop; Deal Wins, FY25 Guidance To Be Watched -
1:10 Split Coming Up: Crorepati FMCG ITC Turns Rs 1,50,000 To Rs 1.2 Crore; Makes Big Announcement; BUY?
7 Stocks To Buy With Potential Upside of Up To 51% From Sharekhan
Sharekhan's Value Report for the month of Sept 2021 has some interesting stocks to buy. We have pulled 7 stocks that have a "buy" call from its Value Report, which can yield returns of as high as 51.1% from the current market price of the stocks. We are not saying that all 7 can gain 51%, we are emphasizing that they are up to 51% as per the report.
7 stocks that you can buy according to Sharekhan’s Value Report
| Company Name | Current market price, Sept 10 | Target price (Sharekhan) | Gains % |
| Zee Entertainment | Rs 182 | Rs 275 | 51.1% |
| Granules India | Rs 328 | Rs 475 | 44.82% |
| TCI Ltd | Rs 427 | Rs 541 | 26.87% |
| Va Tech Wabag | Rs 335 | Rs 435 | 29.85% |
| Sadhbhav Engineering | Rs 51 | Rs 68 | 33.33% |
| Power Grid | Rs 173 | Rs 217 | 25.43% |
| NTPC | Rs 117 | Rs 140 | 19.66% |
Zee Entertainment has an upside potential
According to the report, Zee Entertainment has the best potential from amongst these 7 stocks to generate returns. The stock has over the years taken a knock as the promoters pledged shares to pay of their debts became an issue.
However, the founder of the group Subhash Chandra said that nearly 91.25 of the total debt to lenders has been settled.
"I am happy to report that we have come out of the financial stress situation by settling 91.2% of our total debt to 43 lenders in 110 accounts. About 88.3% of the amount has been paid, while the remaining 2.9% is in the process of being paid. We are making all the required efforts to settle the remaining 8.8% of our total debt," Chandra said in an open letter.
Granules India, TCI Ltd are other stocks that can deliver
According to Sharekhan's report the other stocks that can deliver is Granules India and TCI Ltd. Recently, Granules India received licence from Defence Research & Development Organisation to manufacture and market Covid-19 treatment drug, 2- Deoxy-D-Glucose (2-DG). Developed by DRDO, 2-DG has been granted permission b y the Drug Controller for emergency use as adjunct therapy in moderate to severe Covid-19 patients, Granules India has said. However, unlike most of the markets the stock has already run-up.
From time to time, while we do highlight reports of brokerages, we wish to point out that the markets are overvalued at the moment based on price to earnings for Sensex companies. According to broking firm Motilal Oswal, the Sensex is currently trading at 18% premium to long term averages, and hence prudence would be better. Staggered investing is the best bet when the markets are buoyant. Investors should exercise a degree of caution give the way the markets have rallied in the last 2-3 months. In fact, 1,000 points gain on the Nifty has come in just 19 trading sessions, which makes it time to be cautious.
Disclaimer
The article is informational in nature, which is taken from the brokerage report of Sharekhan. Please do consult a professional advisor before you invest in equities. Greynium Information Technologies Pvt Ltd, its subsidiaries, associates and authors do not accept culpability for losses and/or damages arising based on information in the article.
